Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| University of Oxford, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| University of Oxford, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| University of Oxford, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| University of Oxford, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 9 | 1 |
| University of Oxford, Medical Devices Deals, 2010 to YTD 2016 | 10 | 1 |
| University of Oxford, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 11 | 4 |
| University of Oxford, Pharmaceuticals &Healthcare, Deal Details | 15 | 38 |
| Venture Financing | 15 | 1 |
| Genomics Raises USD16 Million in Venture Financing | 15 | 2 |
| Adaptimmune Raises USD104 Million in Series A Venture Financing | 17 | 2 |
| Oxitec Raises USD10.2 Million in Venture Financing | 19 | 2 |
| Chronos Therapeutics Raises US$13 Million In Venture Financing | 21 | 2 |
| Partnerships | 23 | 1 |
| Idogen Enters into Agreement with University of Oxford | 23 | 1 |
| Sound Pharma to Partner with University of Oxford | 24 | 1 |
| Summit Therapeutics Enters into Agreement with University of Oxford | 25 | 1 |
| Genomics Enters into Agreement with Oxford University and Oxford University Hospitals NHS | 26 | 1 |
| Wave Life Sciences Enters into Research Agreement with University of Oxford | 27 | 1 |
| Cell Therapy Catapult, Plasticell and University of Oxford Enter into Agreement | 28 | 1 |
| Emergent BioSolutions Signs Agreement with Oxford University, GlaxoSmithKline and NIAID for the Production of an MVA Ebola Zaire Vaccine Candidate | 29 | 2 |
| Chan Soon-Shiong Institute Forms Joint Venture with University of Oxford | 31 | 1 |
| Bayer HealthCare Enters Co-Development Agreement with University of Oxford | 32 | 1 |
| MRC Technology Enters Into Co-Development Agreement With Oxford University | 33 | 1 |
| Creeyan Labs Enters Into Co-Development Agreement With Oxford University | 34 | 1 |
| iQur Enters Into Co-Development Agreement With Edward Jenner Institute For Malaria Vaccine | 35 | 1 |
| Emerald Biostructures Enters Into Co-Marketing Agreement With University of Oxford For PiMS Technology | 36 | 1 |
| Population Genetics Technologies Enters Into Co-Development Agreement With University of Oxford | 37 | 1 |
| Novo Nordisk Enters Into Co-Development Agreement With Oxford University | 38 | 1 |
| UCB Enters Into Co-Development Agreement With Oxford University | 39 | 1 |
| ValiRx Enters Into Co-Development Agreement With Oxford University | 40 | 1 |
| Cancer Research UK Enters Into Joint Venture Agreement With University Of Oxford And Oxford Radcliffe | 41 | 1 |
| Sanofi-Aventis And Oxford University Enter Into Research Agreement With INDOX | 42 | 2 |
| Kennedy Institute of Rheumatology Trust Enters Into Collaboration Agreement With University of Oxford | 44 | 1 |
| Isconova Enters Into Agreement With Jenner Institute To Develop Vaccines | 45 | 1 |
| Oxford Nanopore Technologies Enters Into Collaboration With University Of Oxford | 46 | 1 |
| Licensing Agreements | 47 | 1 |
| Vaccitech Enters into Licensing Agreement with University of Oxford | 47 | 1 |
| Rogne Bioscience Enters Into Licensing Agreement with Isis Innovation | 48 | 1 |
| ExpreS2ion Biotech Enters Into Licensing Agreement With University of Oxford For ExpreS2 | 49 | 1 |
| Oxford Nutrascience Enters Into Licensing Agreement With Isis Innovation | 50 | 1 |
| Imaxio Enters Into Licensing Agreement With Isis Innovation | 51 | 1 |
| Equity Offering | 52 | 1 |
| Perspectum Diagnostics Raises USD5 Million in Financing | 52 | 1 |
| University of Oxford - Key Competitors | 53 | 1 |
| Key Employees | 54 | 1 |
| Locations And Subsidiaries | 55 | 2 |
| Head Office | 55 | 1 |
| Other Locations &Subsidiaries | 55 | 2 |
| Appendix | 57 | 1 |
| Methodology | 57 | 1 |
| About GlobalData | 57 | 1 |
| Contact Us | 57 | 1 |
| Disclaimer | 57 | 1 |